| New drugs from old. | |
| | |
MedLine Citation:
|
PMID: 17067118 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The NHS spends over pound10 billion each year on medicines. The use of generic (patent-expired) medicines rather than branded equivalents has a key role in containing this expenditure and ensuring best value for money. On average, 4 years after the patent of a branded medicine has expired in the UK, generic equivalents will account for around half of the drug's market and cost about a quarter as much as the original brand. This represents a potentially large loss of income and, therefore, a major concern for companies that market branded products. Consequently, many use a long-term strategy known as 'lifecycle management' to minimise loss and to maximise returns from such products. This encompasses prioritising products for development, forming strategic alliances with other companies to share resourses, and utilising legal processes to protect products. One part of this strategy is the development and intensive marketing of new formulations or derivatives of existing medicines nearing the end of their patent life. Here we highlight some key examples of the impact the marketing of such products can have on patients, prescribers and the NHS. |
| | |
Authors:
|
- |
Related Documents
:
|
10170328 - Should you take your brand to where the action is? 10261818 - Mediation. a problem-solving strategy. 22207698 - Random versus blocked practice in treatment for childhood apraxia of speech. 10285758 - The user's guide: a key to enhanced communication. 15162888 - From dialysis outcomes quality initiative to kidney disease outcomes quality initiative... 15275978 - Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first w... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Drug and therapeutics bulletin Volume: 44 ISSN: 0012-6543 ISO Abbreviation: Drug Ther Bull Publication Date: 2006 Oct |
Date Detail:
|
Created Date: 2006-10-27 Completed Date: 2007-01-11 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0112037 Medline TA: Drug Ther Bull Country: England |
Other Details:
|
Languages: eng Pagination: 73-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Chemistry, Pharmaceutical Drug Combinations Drug Design* Marketing Patents as Topic Technology, Pharmaceutical* |
| Chemical | |
Reg. No./Substance:
|
0/Drug Combinations |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ionic channels underlying cardiac automaticity: new insights from genetically-modified mouse strains...
Next Document: Can pemetrexed help in malignant mesothelioma?